{"id":75890,"date":"2022-10-19T09:37:47","date_gmt":"2022-10-19T09:37:47","guid":{"rendered":"https:\/\/loopbeatzz.info\/wp\/shareholder-investigation-halper-sadeh-llc-investigates-knbe-cybe-eq-mnrl-rmed-cyberoptics-nasdaq-benzinga\/"},"modified":"2022-10-19T09:37:47","modified_gmt":"2022-10-19T09:37:47","slug":"shareholder-investigation-halper-sadeh-llc-investigates-knbe-cybe-eq-mnrl-rmed-cyberoptics-nasdaq-benzinga","status":"publish","type":"post","link":"https:\/\/loopbeatzz.info\/wp\/shareholder-investigation-halper-sadeh-llc-investigates-knbe-cybe-eq-mnrl-rmed-cyberoptics-nasdaq-benzinga\/","title":{"rendered":"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNBE, CYBE, EQ, MNRL, RMED &#8211; CyberOptics (NASDAQ &#8211; Benzinga"},"content":{"rendered":"<p><span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"legendSpanClass\"><span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"xn-location\">NEW YORK<\/span><\/span>, <span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"legendSpanClass\"><span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"xn-chron\">Oct. 18, 2022<\/span><\/span> \/PRNewswire\/ &#8212; Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and\/or breaches of fiduciary duties to shareholders relating to:<br \/><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><u xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">KnowBe4, Inc. <span class=\"ticker\" data-ticker=\"KNBE\" data-exchange=\"NASDAQ\" style=\"display:inline-block\">KNBE<\/span>&#x27;s<\/u><\/b>\u00a0sale to Vista Equity Partners for <span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"xn-money\">$24.90<\/span> per share in cash. <b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">If you are a KnowBe4 shareholder, <\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3681266-1&amp;h=3282261910&amp;u=https%3A%2F%2Fhalpersadeh.com%2Factions%2Fknowbe4-inc%2F&amp;a=click+here+to+learn+more+about+your+rights+and+options\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">click here to learn more about your rights and options<\/a><\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">.<\/b><br \/><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><u xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">CyberOptics Corporation <span class=\"ticker\" data-ticker=\"CYBE\" data-exchange=\"NASDAQ\" style=\"display:inline-block\">CYBE<\/span>&#x27;s<\/u><\/b>\u00a0sale to Nordson Corporation for <span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"xn-money\">$54.00<\/span> per share.\u00a0<b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">If you are a CyberOptics shareholder, <\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3681266-1&amp;h=653434076&amp;u=https%3A%2F%2Fhalpersadeh.com%2Factions%2Fcyberoptics-corporation%2F&amp;a=click+here+to+learn+more+about+your+rights+and+options\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">click here to learn more about your rights and options<\/a><\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">.<\/b>\u00a0\u00a0<br \/><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><u xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">Equillium, Inc. <span class=\"ticker\" data-ticker=\"EQ\" data-exchange=\"NASDAQ\" style=\"display:inline-block\">EQ<\/span>&#x27;s<\/u><\/b>\u00a0merger with Metacrine Inc.\u00a0<b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">If you are an Equillium shareholder, <\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3681266-1&amp;h=710563927&amp;u=https%3A%2F%2Fhalpersadeh.com%2Factions%2Fequillium-inc%2F&amp;a=click+here+to+learn+more+about+your+rights+and+options\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">click here to learn more about your rights and options<\/a><\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">.<\/b>\u00a0\u00a0<br \/><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><u xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">Brigham Minerals, Inc. <span class=\"ticker\" data-ticker=\"MNRL\" data-exchange=\"NYSE\" style=\"display:inline-block\">MNRL<\/span>&#x27;s<\/u><\/b>\u00a0merger with Sitio Royalties Corp. Under the terms of the merger agreement, Brigham shareholders will receive a fixed exchange ratio of 1.133 shares of common stock in the combined company for each share of Brigham common stock owned on the closing date. Upon completion of the transaction, Brigham shareholders will own approximately 46.0% of the combined entity on a fully diluted basis. <b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">If you are a Brigham shareholder, <\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3681266-1&amp;h=3178209491&amp;u=https%3A%2F%2Fhalpersadeh.com%2Factions%2Fbrigham-minerals-inc%2F&amp;a=click+here+to+learn+more+about+your+rights+and+options\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">click here to learn more about your rights and options<\/a><\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">.<\/b><br \/><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><u xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">Ra Medical Systems, Inc. <span class=\"ticker\" data-ticker=\"RMED\" data-exchange=\"NYSE\" style=\"display:inline-block\">RMED<\/span>&#x27;s<\/u><\/b>\u00a0merger with Catheter Precision, Inc.\u00a0<b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">If you are a Ra Medical shareholder, <\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3681266-1&amp;h=3623956668&amp;u=https%3A%2F%2Fhalpersadeh.com%2Factions%2Fra-medical-systems-inc%2F&amp;a=click+here+to+learn+more+about+your+rights+and+options\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">click here to learn more about your rights and options<\/a><\/b><b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">.<\/b>\u00a0\u00a0<\/p>\n<p>Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.<br \/>Shareholders are encouraged to contact the firm <b xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"><u xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\">free of charge<\/u><\/b> to discuss their legal rights and options. Please call <span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"xn-person\">Daniel Sadeh<\/span> or <span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"xn-person\">Zachary Halper<\/span> at (212) 763-0060 or email <a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"mailto:sadeh@halpersadeh.com\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">sadeh@halpersadeh.com<\/a>\u00a0or <a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"mailto:zhalper@halpersadeh.com\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">zhalper@halpersadeh.com<\/a>.<br \/>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.<br \/>Attorney Advertising. Prior results do not guarantee a similar outcome.<br \/>Contact Information:<br xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"\/>Halper Sadeh LLC<br xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"\/><span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"xn-person\">Daniel Sadeh, Esq.<\/span><br xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"\/><span xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"xn-person\">Zachary Halper, Esq.<\/span><br xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"\/>(212) 763-0060<br xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"\/><a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"mailto:sadeh@halpersadeh.com\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">sadeh@halpersadeh.com<\/a><br xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"\/><a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"mailto:zhalper@halpersadeh.com\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">zhalper@halpersadeh.com<\/a><br xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" class=\"core-block\"\/><a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3681266-1&amp;h=887049822&amp;u=https%3A%2F%2Fwww.halpersadeh.com%2F&amp;a=https%3A%2F%2Fwww.halpersadeh.com\" target=\"_blank\" rel=\"nofollow noopener\" class=\"core-block\">https:\/\/www.halpersadeh.com<\/a><\/p>\n<div class=\"CoreElement__CoreElementWrapper-sc-16x4s4x-0 fVdoNG\"><span style=\"background:none;border:0;box-sizing:border-box;display:inline-block;height:initial;margin:0;opacity:1;overflow:hidden;padding:0;width:initial;position:relative;max-width:100%\"><span style=\"background:none;border:0;box-sizing:border-box;display:block;height:initial;margin:0;opacity:1;padding:0;width:initial;max-width:100%\"><img data-opt-id=539451468  fetchpriority=\"high\" decoding=\"async\" alt=\"\" aria-hidden=\"true\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMTIiIGhlaWdodD0iMTIiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgdmVyc2lvbj0iMS4xIi8+\" style=\"background:none;border:0;display:block;height:initial;margin:0;max-width:100%;opacity:1;padding:0;width:initial\"\/><\/span><img data-opt-id=758893364  fetchpriority=\"high\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" decoding=\"async\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"\/><noscript><img data-opt-id=524776203  fetchpriority=\"high\" sizes=\"(max-width: 800px) 12px, (min-width: 800px) 12px\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY06946&amp;sd=2022-10-18?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=32\" srcset=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY06946&amp;sd=2022-10-18?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=16 1x, https:\/\/c212.net\/c\/img\/favicon.png?sn=NY06946&amp;sd=2022-10-18?optimize=medium&amp;dpr=2&amp;auto=webp&amp;width=32 2x\" decoding=\"async\" loading=\"lazy\" style=\"border:none;bottom:0;box-sizing:border-box;display:block;height:0;left:0;margin:auto;max-height:100%;max-width:100%;min-height:100%;min-width:100%;padding:0;position:absolute;right:0;top:0;width:0;object-fit:contain\"\/><\/noscript><\/span><\/div>\n<p> View original content to download multimedia:<a xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\" id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/shareholder-investigation-halper-sadeh-llc-investigates-knbe-cybe-eq-mnrl-rmed-301652359.html\" target=\"_blank\" class=\"core-block\">https:\/\/www.prnewswire.com\/news-releases\/shareholder-investigation-halper-sadeh-llc-investigates-knbe-cybe-eq-mnrl-rmed-301652359.html<\/a><br \/>SOURCE  Halper Sadeh LLP<br \/>\u00a9 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.<\/p>\n<p><a href=\"https:\/\/www.benzinga.com\/pressreleases\/22\/10\/n29310026\/shareholder-investigation-halper-sadeh-llc-investigates-knbe-cybe-eq-mnrl-rmed\">source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Oct. 18, 2022 \/PRNewswire\/ &#8212; Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and\/or breaches of fiduciary duties to shareholders relating to:KnowBe4, Inc. KNBE&#x27;s\u00a0sale to Vista Equity Partners for $24.90 per share in cash. If you are a KnowBe4 shareholder, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":75891,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-75890","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/posts\/75890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/comments?post=75890"}],"version-history":[{"count":0,"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/posts\/75890\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/media\/75891"}],"wp:attachment":[{"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/media?parent=75890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/categories?post=75890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/loopbeatzz.info\/wp\/wp-json\/wp\/v2\/tags?post=75890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}